DrugPatentWatch Database Preview
Drugs in Development Information for Cannabidivarin
» See Plans and Pricing
What is the drug development status for Cannabidivarin?
Cannabidivarin is an investigational drug.
There have been 6 clinical trials for Cannabidivarin.
The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2017.
The most common disease conditions in clinical trials are Disease, Child Development Disorders, Pervasive, and Autistic Disorder. The leading clinical trial sponsors are GW Research Ltd, Montefiore Medical Center, and Foundation for Prader-Willi Research.
There are twenty-nine US patents protecting this investigational drug and one hundred and fifty-three international patents.
Summary for Cannabidivarin
| US Patents | 29 |
| International Patents | 153 |
| US Patent Applications | 70 |
| WIPO Patent Applications | 132 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2017-10-01) |
| Vendors | 11 |
Recent Clinical Trials for Cannabidivarin
| Title | Sponsor | Phase |
|---|---|---|
| CBDV vs Placebo in Children With Prader Willi Syndrome PWS | Foundation for Prader-Willi Research | Phase 2 |
| CBDV vs Placebo in Children With Prader Willi Syndrome PWS | Montefiore Medical Center | Phase 2 |
| Safety and Tolerability of Cannabidivarin (CBDV) in Children and Young Adults With Autism Spectrum Disorder | GW Research Ltd | Phase 2 |
Clinical Trial Summary for Cannabidivarin
Top disease conditions for Cannabidivarin
Top clinical trial sponsors for Cannabidivarin
US Patents for Cannabidivarin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Cannabidivarin | Start Trial | Enhanced smokable therapeutic cannabis product and method for making same | CMG PARTNERS, INC. (San Jose, CA) | Start Trial |
| Cannabidivarin | Start Trial | Cannabis-based therapeutic product for treatment of chronic pain | CMG PARTNERS, INC. (San Jose, CA) | Start Trial |
| Cannabidivarin | Start Trial | Cannabinoid composition and products including .alpha.-tocopherol | Constance Therapeutics, Inc. (San Francisco, CA) | Start Trial |
| Cannabidivarin | Start Trial | Food and beverage compositions infused with lipophilic active agents and methods of use thereof | Start Trial | |
| Cannabidivarin | Start Trial | Food and beverage compositions infused with lipophilic active agents and methods of use thereof | Start Trial | |
| Cannabidivarin | Start Trial | Cannabis oil extracts and compositions | CONSTANCE THERAPEUTICS, INC. (San Francisco, CA) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Cannabidivarin
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Cannabidivarin | World Intellectual Property Organization (WIPO) | WO2018226899 | 2037-06-06 | Start Trial |
| Cannabidivarin | World Intellectual Property Organization (WIPO) | WO2018227017 | 2037-06-06 | Start Trial |
| Cannabidivarin | World Intellectual Property Organization (WIPO) | WO2019173242 | 2037-06-06 | Start Trial |
| Cannabidivarin | World Intellectual Property Organization (WIPO) | WO2019178088 | 2037-06-06 | Start Trial |
| Cannabidivarin | World Intellectual Property Organization (WIPO) | WO2018226899 | 2037-06-06 | Start Trial |
| Cannabidivarin | World Intellectual Property Organization (WIPO) | WO2018227017 | 2037-06-06 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
